CROM Symposium, Online, 2023, CROM 04
Abuse liability assessment of CNS-active drugs in development: history and overview
Pinney Associates, Inc., Bethesda, MD, USA
The Controlled Substances Act (CSA) describes eight factors that need to be examined to assess the abuse potential (or liability) of drugs in clinical development that are active within the central nervous system (CNS). These factors encompass a wide...